Results 1 to 10 of about 13,399 (295)

Antibiotic Resistance Mechanisms Inform Discovery: Identification and Characterization of a Novel Amycolatopsis Strain Producing Ristocetin [PDF]

Antimicrobial Agents and Chemotherapy, 2014
Discovering new antibiotics is a major scientific challenge, made increasingly urgent by the continued development of resistance in bacterial pathogens.
Andrew W. Truman, Min Jung Kwun, Jinhua Cheng, Seung Hwan Yang, Joo‐Won Suh, Hee‐Jeon Hong   +5 more
semanticscholar   +6 more sources

Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor

Blood, 2010
Veronica H Flood, B R Branchford
exaly   +4 more sources

Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury

Journal of Trauma and Acute Care Surgery, 2018
BACKGROUND Injury to the blood-brain barrier exposes endothelium rich in von Willebrand factor (vWF), which may play a role in altered platelet aggregation following traumatic brain injury (TBI).
Lucy Z Kornblith, Anamaria J Robles
exaly   +2 more sources

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Leukemia, 2016
Bleeding because of impaired platelet function is a major side effect of the Bruton’s tyrosine kinase (BTK) inhibitor ibrutinib. We quantitatively assessed ristocetin-induced platelet aggregation (RIPA) in 64 patients with chronic lymphocytic leukemia ...
Alexander Egle
exaly   +2 more sources

Draft Genome Sequence of Ristocetin-Producing Strain Amycolatopsis sp. Strain MJM2582 Isolated in South Korea

Genome Announcements, 2014
The draft genome sequence of a ristocetin-producing Amycolatopsis strain (sp. MJM2582) isolated in South Korea is reported here. This strain has a genome of approximately 8.9 Mb containing 7,933 predicted genes, including the ristocetin cluster and 32 ...
Min Jung Kwun, Jinhua Cheng, Seung Hwan Yang, Dong‐Ryung Lee, Joo‐Won Suh, Hee‐Jeon Hong   +5 more
openalex   +2 more sources

Thrombocytosis and bleeding in myeloproliferative neoplasms: exploring clinical diversity and risk of acquired von Willebrand syndrome—insights from a UK center [PDF]

Research and Practice in Thrombosis and Haemostasis
Background: Myeloproliferative neoplasms (MPNs) represent a group of blood disorders characterized by myeloid cell proliferation and an associated increased risk of thrombosis and bleeding.
Giulia Simini, Andrew Innes, Saravanan Vinayagam, Golzar Mobayen, Nilanthi Karawitage, Simone Claudiani, Zain Odho, Mike Laffan, Deepa J. Arachchillage   +8 more
doaj   +2 more sources

Studies with a murine monoclonal antibody that abolishes ristocetin- induced binding of von Willebrand factor to platelets: additional evidence in support of GPIb as a platelet receptor for von Willebrand factor [PDF]

Blood, 1983
BS Coller, EI Peerschke, LE Scudder, CA Sullivan   +3 more
semanticscholar   +3 more sources

A murine antiglycoprotein Ib complex monoclonal antibody, SZ 2, inhibits platelet aggregation induced by both ristocetin and collagen [PDF]

Blood, 1987
CG Ruan, XP Du, XD Xi, PA Castaldi, MC Berndt   +4 more
semanticscholar   +4 more sources

Differential sensitivity of von Willebrand factor (VWF) ‘activity’ assays to large and small VWF molecular weight forms: a cross‐laboratory study comparing ristocetin cofactor, collagen‐binding and mAb‐based assays

Journal of Thrombosis and Haemostasis, 2012
E. J. Favaloro, R. Bonar, K. Chapman, M. Meiring, D. F. Adcock   +4 more
exaly   +2 more sources

Limitations of the ristocetin cofactor assay in measurement of von Willebrand factor function

Journal of Thrombosis and Haemostasis, 2009
V. Flood, Kenneth D. Friedman, J. C. Gill, J. C. Gill, P. A. Morateck, Jeffrey S. Wren, J. P. Scott, J. P. Scott, Robert R Montgomery, Robert R Montgomery   +9 more
exaly   +2 more sources